CABG boosts outcomes in diabetes plus multivessel CAD

11/4/2012 | Healio (free registration)

Data on 1,900 patients with diabetes and multivessel coronary artery disease showed those who underwent coronary artery bypass grafting had lower rates of all-cause mortality, nonfatal myocardial infarction or nonfatal stroke at five years compared with those who had percutaneous coronary intervention with a drug-eluting stent. Lower rates of cardiovascular and cerebrovascular events were also seen in the CABG group, researchers said. The results were presented at the American Heart Association meeting.

View Full Article in:

Healio (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC